Pharmaceuticals, Biotechnology and Life Sciences
Financial Results and Operational Update for the Full Year Ended June 30, 2025NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) —…
WOODCLIFF LAKE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced…
All dollar amounts reflected in Canadian dollars unless otherwise statedVANCOUVER, British Columbia, Aug. 28, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics…
EUGENE, Ore., Aug. 28, 2025 (GLOBE NEWSWIRE) — Cascade Prodrug, Inc. (“Cascade”), a biotechnology company focused on advancing novel Hypoxia…
WINNIPEG, Manitoba, Aug. 28, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announced…
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology…
SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) — Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially…
SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition…
CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company…
BURLINGTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) — Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”), a clinical-stage biotechnology…